How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Investigation of Possible Intraoperative Transmission of Brucella melitensis, Slovenia – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Organ Donor Transmission of Rickettsia typhi to Kidney Transplant Recipients, Texas, USA, 2024 – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Communicable disease threats report, 13 – 19 September 2025, week 38

Early Release – A Personal Journey Through the Microbial World in Quilting – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Disseminated Blastomycosis Mimicking Tuberculosis, China – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Emerging Sexual Transmission of Trichophyton mentagrophytes Genotype VII Infections, United States – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Malassezia [mal″ə-sē′zhə] – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Neonatal Gonococcal Conjunctivitis Caused by Fluoroquinolone-Resistant Neisseria gonorrhoeae – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Crimean-Congo Hemorrhagic Fever Virus Circulation in Wild European Rabbits, Portugal, 2018−2023 – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Detection of Immunity Gap before Measles Outbreak, Ho Chi Minh City, Vietnam, 2024 – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us